|
|
Drug policy in Czech Republic
Vasiliaková, Beáta ; Maaytová, Alena (advisor) ; Vítek, Leoš (referee)
Thesis is focused on drug system development in Czech Republic during years 2000 to 2008, on study of present circumstances and on key features comparison with its development in selected European countries. Author has described drug system functioning, its participants and relations among them set to Czech Republic. Attention is paid especially to sources of rise in prices of drugs and to growth in consumption, then to safety and awareness of current medication. Factors effecting total expenses on drugs are investigated and participation of total expenses on drugs on total health expenses is analyzed. Due to the international comparison there is pronounced conviction that the increase in drug expenses has become a global phenomenon of todays which is to be solved. Great emphasis is placed on questionable segments of drug policy in Czech Republic and on potentials of its improvements in this performance, too.
|
|
|
Regulation of Advertising of Drugs - Education of Consumer
Rojko, Ivan ; Durdisová, Jaroslava (advisor) ; Minárik, Pavol (referee)
The main objective of my diploma thesis was to explain the principles and basic terms of drug policy in the Czech Republic, and to illustrate all the issues of government regulations in this area. This paper is trying to confront two different kinds of health services. The first one based on liberal principles, without any government intervention (system in USA), and the second one demarcating with regulations and restrictions, devoid of any free market fundamentals (system in EU). It describes the relationship between patient and doctor, and points out the different number of information, they dispose of. This paper is trying to explain the problem of skewed distribution of information in society. It presents how the government regulations in the free market area destroy the source allocation efficiency and goes against the satisfaction of customers' needs.
|
|
|
Kategorizace léčiv
Slanařová, Eliška Bc. ; Lešetický, Ondřej (advisor) ; Střítecký, Rudolf (referee)
Farmaceutický průmysl je velmi prestižním odvětvím, ve kterém se točí spousta peněz. Pro rok 2006 bylo za léčiva utraceno 64 miliard Kč. Kategorizace léčiv je jedním z nástrojů lékové politiky, jak zamezit stále rostoucím nákladům na farmakoterapii. Práce podává souhrnný přehled o jednotlivých stakeholders v oblasti lékové politiky, vývoji lékové politiky v ČR, spotřebě léčiv a celkově analyzuje situaci v ČR.
|
|
| |
guest ::
